TAVI (Transcatheter aortic valve implantation)

This session explores leaflet modification techniques during TAVI, focusing on complex valve-in-valve procedures supported by artificial intelligence-powered planning and advanced imaging. Case discussions cover challenges such as low valve-to-coronary distances, bi-leaflet obstruction, and strategies to maintain coronary flow and hemodynamic stability.

Delve into the next wave of transcatheter interventions disrupting the aorta and valves. This session covers pioneering minimally invasive ascending aortic repair, novel polymeric aortic valve implants, and innovative devices for tricuspid repair and leaflet replacement.

An intensive rapid-fire session presenting the latest advancements in next-generation structural heart and valve therapies, including novel transcatheter systems for aortic and mitral valve repair, innovative solutions for tricuspid regurgitation, and implant-free PFO closure technologies.

In this discussion, Matti Adam and Didier Tchétché explore how to optimise the index TAVI procedure in younger, low-risk patients, emphasising the importance of achieving excellent hemodynamic results, ensuring long-term durability, maintaining coronary access, and planning for potential redo procedures. Patient anatomy and high-quality imaging remain...

Nicolas Dumonteil and Stefan Blankenberg discuss the long-term durability of transcatheter heart valves and the implications for the future of TAVI.

Reviewing the latest evidence, including the 7-year results from PARTNER 3 and extended follow-up from Evolut Low Risk, they highlight the reassuring outcomes observed for death...

At EuroPCR 2026, Andreas Baumbach, Philippe Garot and Rutger-Jan Nuis discuss three important trials that could help shape the future management of aortic stenosis.

The BASELINE trial compares self-expanding and balloon-expandable valves in patients undergoing valve-in-valve TAVI for a failing surgical bioprosthesis. The START YOUNG trial focuses...

Andreas Baumbach and Raj Makkar explore the latest developments in TAVI for aortic regurgitation. They review the emergence of dedicated transcatheter devices designed for patients with symptomatic aortic regurgitation who are at high surgical risk or unsuitable for surgery, and discuss the evidence supporting their use.

The conversation...

Birgid Gonska, Henryk Dreger and Christophe Saint Etienne review the one-year results of the VANTAGE trial evaluating the Navitor TAVI device in younger, low- and intermediate-risk patients, showing very favourable outcomes with a low composite rate of mortality and disabling stroke (2.6%), very good valve performance,...

Ole De Backer and Daniel Blackman discuss the management of coronary artery disease in TAVI candidates and whether PCI should be performed before valve implantation or safely deferred.

They review PROTAVI, which supports a selective strategy with PCI only when clinically indicated, with a signal toward less...

Watch this replay to learn how to anticipate anatomical challenges and optimize TAVI planning in complex tricuspid AS cases.

A 69-year-old woman with severe symptomatic aortic stenosis (NYHA III) and complex comorbidities, including three-vessel coronary artery disease, advanced COPD, and peripheral artery disease, presents with progressive dyspnoea despite recent PCI. How would you treat this patient?

Join A. Öner, D. Buckert and A. Khokhar as they explore multidisciplinary decision-making, lifetime management in low and intermediate-risk TAVI patients.

In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.

When standard catheters and wires repeatedly fail to cross a severely stenotic aortic valve, a simple modification of readily available equipment may provide a solution.

This step-by-step tutorial explains how to create and use a self-made steerable catheter system to facilitate valve crossing in complex TAVI anatomies.

An 85-year-old man presented in cardiogenic shock with torrential aortic regurgitation after prior surgical and TAVI valve-in-valve procedures. With high coronary obstruction risk, urgent CT assessment and in-silico simulations guided a rapid redo TAVI-in-TAVI-in-valve implantation, demonstrating that CT-assisted emergency redo-TAVI is feasible and lifesaving in high-risk...

Discover the latest insights on TAVI durability in this replay, where O. Demir, T. Nestelberger and T. Rheude break down the evidence and highlight what it means for clinical practice and long‑term patient care.

A 68-year-old woman presents with symptomatic aortic stenosis and tricuspid valve anatomy, with no significant comorbidities and no evidence of coronary artery disease. Given her strong preference for a less invasive strategy, the Heart Team considers a transcatheter approach.
How would you treat this patient—and in case...

Women have long been underrepresented in TAVR trials. This article explores the DEDICATE trial’s sex-specific outcomes after TAVI and SAVR, revealing differences in early stroke risk, procedural challenges, and one-year survival in men and women with aortic stenosis.

In this article, Ahmed Abdelhafez and Mohamed Abdel-Wahab review the key principles of redo TAVI, a procedure set to become increasingly common as TAVI expands to younger and lower-risk patients. They discuss the major challenges of coronary obstruction, device selection, and implantation strategy, highlighting how careful...

In this expert review, Won-Keun Kim discusses key considerations for patient‑tailored transcatheter heart valve selection in index TAVI procedures, highlighting how valve type and design influence procedural success, long‑term outcomes, and lifetime management.